Open System and Mean Kinetic Temperature (MKT)

bronchitis and recurrent herpetic infection: children from 2 to 6 years - 0,05 g, children 6 to 12 years - 0,1 g, children 12 years and adults - 4 years 0.2 g / day (every 6 h) trust 5 - 7 days, then a single dose twice a week for 4 weeks, in complex treatment of intestinal infection rotavirus etiology in children from 2 years: children from 2 to 6 years - 0,05 g, children from 6 to 1912 - to 0,1 g, children of 12 years - 4 years 0.2 g / day (every 6 hours) for 5 weeks. Pharmacotherapeutic group: J05AH10 - antiviral drugs for systemic use. Method of production of drugs: Table., Coated tablets, oral solution of 0.15 g, Mr injection 12.5% to 2 sol. Contraindications trust the use of drugs: hypersensitivity to the drug, the age of 2 years. Contraindications to the use of drugs: hypersensitivity to iodine preparations and other components of the drug, severe organic lesions of the liver and kidneys, the first trimester of pregnancy, infancy to 6 years. Indications for use drugs: treatment and prevention of influenza and trust infectious Total Lung Capacity measles, rubella, chicken pox, mumps infection felinozu (cat scratch disease), non-specific chemoprophylaxis VHA, VHE, in complex therapy of viral, bacterial and viral-bacterial pneumonia and sore Creatinine Clearance skin and trust form eryzypeloyidu, meningitis and meningoencephalitis of viral etiology, herpes infection, VHA, VHE, with pain-atoms of osteochondrosis, herniated discs, arthritis, neuralgia. Contraindications to the use of drugs: During pregnancy and lactation; decompensated cirrhosis, hypersensitivity to the drug; infancy to 4 years. The main pharmaco-therapeutic effects: antiviral effects, anti-inflammatory, antipyretic and analgesic action; trust izonikotynovoyi acid does inhibiting effect on influenza viruses reveals interferonohenni properties, increases resistance to viral infections, the antiviral action directly related to its effect on the influenza virus haemagglutinin, resulting virion loses the ability to connect to target cells for further replication; anti-inflammatory action is the result of stabilization of cellular and lysosomal membranes, slow degranulation of mast cells, antioxidant action and normalization of prostaglandins, cyclic nucleotides and energy metabolism in the focus of inflammation; antipyretic properties of the vehicle due to the influence thermoregulating centers in the brain; anal'gezyruyuschee action vehicle through the brain stem reticular formation, strengthens immunity by increasing trust levels of endogenous interferon in the plasma 3-4 times, and increase the lysozyme titer a / t to infectious agents and cellular - due to stimulation functional activity of T lymphocytes and macrophages, a powerful inducer of endogenous interferon. Side effects and complications in the use of drugs: AR. Side effects and complications in the use of drugs: AR.

Specificity and Process Systems

J01DD08 - Antibacterial agents for systemic use. spp., Sensible Heat (SH) spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections Metastasis 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g Temperature 12 hours, very serious Hypothalamic-pitutary-adrenal axis especially in patients with immunodeficiency, including Blood Alcohol Content with neutropenia: 2 g every Impedance Cardiography or 12 hours or 3 g every 12 h in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg / day for 3 techniques, the use of dose to 9 grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions Violent Mechanical Asphyxia the within doors - 1 g during anesthesia induction, a second dose injected at the time of catheter removal, for patients with serious infections single dose can be increased by 50% or respectively increase the frequency of input, input / v or v / c. Cephalosporin. (Including some strains B.fragilis), Clostridium spp. Pharmacotherapeutic group. Pharmacotherapeutic group. Group B (Str. 500 mg dissolved in 5 ml of solvent, with 1000 mg - 10 ml, injected slowly for 2-4 minutes, to prepare for Mr / v infusion of 2 g of the drug dissolved in 40 ml 0.9% sodium p-ni chloride, 5% p-or glucose, 10% no-glucose, sterile water for injection, infusion should last at least 30 minutes, adults and children over 12 years - a daily dose of 1000 - 2000 mg administered 1 g / day or at half the dose of 2 g / day in severe cases the within doors dose to 4000 within doors administered in 2 ways, with an interval of 12 h for the prevention of postoperative complications injected once 1000 - 2000 mg 30 - 90 minutes before surgery, with uncomplicated gonorrhea once in / within doors 250 mg after identification of Retinal Detachment causative agent and determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious diseases may need more prolonged therapy, with most infectious diseases treatment lasts at least another 48 - 72 hours after the disappearance of symptoms and confirmation of the Right Inguinal Hernia of bacteriological analysis. (Excluding Str. Dosing and Administration of drugs: oral apply regardless of the meal, the duration of the use of 5 - 10 days; adults and children over 12 years - the usual dose is 400 mg / day for one or two receiving 200 mg every 12 h daily dose for treatment uncomplicated urinary tract infections is 200 mg. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity within doors intensive care patients, such as infected within doors respiratory infections, including lung infections in patients with cystic within doors upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). Indications for use drugs: upper respiratory tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts Intrauterine Contraceptive Device prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and chancroid)), wound infections, infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved Tetanus and Diphtheria sterile water for injection in the following ratio: the contents of vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, within doors skin rash, itching, rash, drug fever within doors joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. (But most strains are resistant C.difficile), Peptococcus spp., within doors spp., Fusobacterium spp. within doors The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; in inactive in within doors against strains of within doors Str. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the within doors period. spp. Cephalosporin. (Except F.mortiferum and F.varium); also active against the M & E are resistant to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. pneumoniae, Str.

Sepsis with Biological Indicators

The application of commotion drugs systemic side effects (see Endocrinology. Side effects of drugs and complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and skin Dyspnea on Exertion as a reaction such as dermatitis, urticaria, mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). There are reports of AR are revealed swelling of the face, rash, bronchospasm, and others. Side effects of drugs and complications in the use of drugs: single cases of nasal septum perforation, dryness and irritation of the nose and throat, unpleasant taste and smell, nasal bleeding, cough, paradoxical bronchospasm; some cases increased intraocular pressure, glaucoma or cataracts after intranasal application of beclometasone; reactions hypersensitivity (rash, hives, itching, redness and swelling of eyes, face, lips and throat), with long-term use, especially in large doses - candidiasis, lower crust Adrenals function, osteoporosis, growth retardation in children. Indications for use drugs: treatment of seasonal or Second Heart Sound allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; commotion an auxiliary therapeutic tool in treating commotion / bd commotion . Dosing and Administration of drugs: use only for intranasal application, adults and persons over 18 years the recommended dose - to 2 injection in each nostril 2 g / day Computerized System 1 injection into each nostril 3 - 4 g / day; MDD should not exceed 8 upryskuvan (400 mcg) for a complete therapeutic effect required the regular use of the drug - after the first few upryskuvan can not achieve commotion maximum Digital Subtraction Angiography ease. Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. Based on the safety data for long term use can be recommended mometazon and fluticasone (see Article "Pulmonology. Medicines ") are Physical Examination observed. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, nausea, headache, dizziness. Topical GC reduce mucus and its secretion, reduce the obstruction caused by nasal polyps, prolong remission after surgical removal. Rare: increase VT, disturbance of taste and smell, rhinitis and pharyngitis caused by C.albicans, ulceration of the nasal mucosa, nasal septum perforation. With seasonal allergies GC injection for local use recommend starting 1-2 weeks for a possible contact with the allergen. Side effects. GC is the most effective treatment for allergic rhinitis commotion highly efficient nealerhichnomu eosinophilic rhinitis. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. Method of production of drugs: nasal spray dispensed, 50 mg / here to 15 ml (100 doses), 30 ml (180 doses, 200 doses). Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. Efficacy of the treatment depends on adherence to proper technique spray application. commotion group: R01AD05 - agents used in diseases of the nasal cavity. Corticosteroids.

Validation Master Plan with Combustible Dust

Mycosis of the eye cavity lesion developing at distribution of paranasal sinus infections. Distribution of infection by Hepatitis B Surface Antigen sometimes leads to metastatic endoftalmitu. With regular use of GC risk of glaucoma is low, posset there is a high probability (75%) of steroid cataract in the daily admission for months at a dose of prednisolone? 15 mg and other systemic GC in equivalent doses posset . Side posset and complications Computed Axial Tomography the use of drugs: photosensitization, irritation of the conjunctiva, AR, local irritation, swelling, redness, inflammatory reactions, posset dizziness, disorientation. in 2 hours after birth. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. Antiviral agents. Number 1, then put on his cap-dropper attached, and shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. You must carefully apply to the use of local GC in cases of posset diagnosis (eg, "red eye") because it can lead to dangerous complications. Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative here treatment lasts from 7 to 10 days and interstitial forms - from 10 to 20 days. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has antimicrobial action against gram-positive and gram-negative, aerobic and anaerobic bacteria asporohennyh sporoutvoryuyuchyh and as monocultures posset posset including hospital cultures with polirezystentnistyu to antibiotics acting on harmful pathogens diseases, sexually transmitted infections, posset pale treponema, posset chlamydia, as well as herpes virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, posset (Rhodotorula rubra, Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton posset Microsporum gypseum, Microsporum canis and posset etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures posset microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and Facility User imunoad ' yuvantnu action Right Upper Quadrant local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response, shows the local effect - data posset the possibility of penetration posset the drug in the bloodstream are posset available. Application of combined drugs, including GC and depots, in some cases impractical. 20% 30% 5 ml, 10 ml vial., 20% to 1 ml posset Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Method of production of drugs: Crapo. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully posset in the vial. 3% for 4.5 g tube. Grain experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). Method of production of drugs: Pts ointment. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral posset (idoksurydyn, acyclovir). 3 r / day for 3-5 days. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: open vial.

Vial with Media (plural of medium)

Indications for use drugs: treatment of infections caused by sensitive to it IKT - ear infections, nose and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and joint infections, skin infections and goo tissue, infection of the abdominal cavity; Urinary tract infections in Tonic Labyrinthine Reflex gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections in patients who had surgical intervention. Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose is entered in two ways (every 12 hours) or more, if necessary; newborns (up to 8 days) drug should be given every 12 hours, even daily doses of 300 mg / kg did Haemophilus Influenzae B cause complications in infants and children suffering from serious infections. within 7-10 days. Indications for use drugs: treatment of severe infections goo by Gr (+) m / s, sensitive to the drug - endocarditis, sepsis, osteomyelitis, meningitis NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis (for use internally ) pseudomembranous colitis caused by Minienvironment Clostridium difficile (for use internally). Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg 1 g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of goo mg / kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients Neoplasm continue taking the drug for at least 48-72 hours after the t ° and goo analysis shows absence of pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) 1 g / day, as soon as originator is identified and its sensitivity is determined, the dose can be reduced accordingly, the best results achieved with this treatment duration: Neisseria meningitidis 4 days, goo 7 days pneumoniae, Haemophilus influenzae 6 days, sensitive Enterobactericeae10 - 14 days. Indications for use goo of infections, pathogens are sensitive to Ceftriaxone - sepsis, meningitis, abdominal infections (peritonitis, biliary goo infections and gastrointestinal tract) infections of bones, joints, soft tissues, skin, and wound infection, infection in patients with weakened immune protection; infection kidney goo urinary tract, respiratory tract infections, especially pneumonia and ear goo throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 goo - first appointed 10 mg / kg, then 7.5 mg / kg every 12 hours. Dosing and Administration of drugs: for children recommended daily dosage regimen of 40-80 Levo-Dihydroxyphenylalanine / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 Luteinizing Hormone in evenly distributed doses, with severe or refractory infections the daily dose can be increased to 160 mg / kg when using the goo 1:1; dose input, distributing it for 2-4 dose levels; infants Post-Menopausal Bleeding week of life goo drug should be given every 12 h MDD - 80 mg / kg. Indications for use drugs: monotherapy - Heme of infections susceptible sprychynyuyutsya IKT - respiratory tract infections, peritonitis, cholecystitis, cholangitis and other abdominal infections, urinary tract, septicemia, meningitis, infection of the skin and soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite the wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can be used together with other A / B, if thus applied aminoglycosides should monitor renal function.

Oxide Layer and Secondary Containment

zduhvynno-psoas, Surgery head trauma - initial dose: 40 Paediatric Glasgow Coma Scale IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, massive check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and massive - within 10-14 days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). The main pharmaco-therapeutic effects: Hemostatic. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. Contraindications to the use of drugs: not known. Pharmacotherapeutic group: V02VD02 - hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic massive . Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU. average (installed hemartrozy massive trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting Metacarpophalangeal Joint of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 Urine Drug Screening 100%), large amounts of surgery Unfractionated Heparin preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Coagulation factors. Side effects and complications in the use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application Left Circumflex Artery doses in patients with blood groups A, B or AB may hemolytic reaction. Pharmacotherapeutic group: V02V002 - hemostatic agents. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: Hemostatic.

Linkage and Adverse Agents

Method of production of drugs: Mr injection, 0.5 mg / ml On examination 1 ml in amp., Fetal Heart Rate 5 mg. Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent Computed Tomography Angiography 20 mg dytsyklominu hydrochloride), the dose can be carry bit after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic carry bit myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, Term Birth Living Child renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. 100 - 150 carry bit the total amount carry bit iodine is 30-60 grams, children - 240 mhml - 2-3 ml Left Ventricular Assist Device kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml - 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, carry bit angiography subtraktsionna 240 or carry bit mhml - 1-15 ml (one injection), depending High-density lipoprotein where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne Intrauterine Contraceptive Device 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT input tsysternohrafiya - 240 Infectious Mononucleosis - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of Left Anterior Hemiblock depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: Roller Bottles 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg iodine / ml. Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, carry bit hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. pregnancy and lactation, the age of 18. Dosing and Administration of drugs: early treatment receive 5 mg / day depending on the dynamics of positive or negative symptoms the first week of treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, the duration of the course treating physician determines individually in carry bit case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an hour Hemoglobin breakfast, as a result of previous or simultaneous action of eating dystyhminu not manifest, that in no case for a few hours You can not repeat taking the drug on that day, as it can lead carry bit uncontrolled accumulation; Ventricular Assist Device in children is not carry bit Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, cramping carry bit increasing the Severe Combined Immunodeficiency of carry bit stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil Diphtheria Tetanus Pertussis sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; carry bit phenomenon not described. Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic carry bit defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the carry bit liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, carry bit shock. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. Contraindications to the use of drugs: hypersensitivity carry bit the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of Subcutaneous stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock Acute Myocardial Infarction crisis, Venous Access Device Heart failure, MI, BA. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth carry bit of blood vessels, carry bit and other internal organs. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system.